HOMEPRODUCTSCOMPANYCONTACTFAQResearchDictionaryPharmaSign Up FREE or Login

Ulrich Feige Selected Research

PEGylated soluble tumor necrosis factor receptor I

5/2005Additive bone-protective effects of anabolic treatment when used in conjunction with RANKL and tumor necrosis factor inhibition in two rat arthritis models.
10/2002Inhibition of interleukin-1 but not tumor necrosis factor suppresses neovascularization in rat models of corneal angiogenesis and adjuvant arthritis.

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.
Realize the full power of the drug-disease research graph!


Choose Username:
Email:
Password:
Verify Password:
Enter Code Shown:


Ulrich Feige Research Topics

Disease

10Arthritis (Polyarthritis)
01/2011 - 07/2002
8Inflammation (Inflammations)
09/2009 - 07/2002
5Experimental Arthritis
01/2009 - 07/2002
3Disease Progression
03/2009 - 07/2002
3Tibial Fractures (Fracture, Tibial)
08/2005 - 12/2002
2Rheumatoid Arthritis
01/2011 - 12/2002
2Leukocytosis (Pleocytosis)
03/2009 - 11/2008
2Osteitis
01/2004 - 07/2002
1Hyperplasia
03/2009
1Bone Resorption
01/2009
1Metabolic Bone Diseases (Osteopenia)
10/2005
1Corneal Neovascularization
10/2002
1Osteoporosis
07/2002

Drug/Important Bio-Agent (IBA)

6Tumor Necrosis Factor-alpha (Tumor Necrosis Factor)IBA
09/2009 - 10/2002
5OsteoprotegerinIBA
01/2009 - 07/2002
3Biomarkers (Surrogate Marker)IBA
03/2009 - 10/2005
3Ethanol (Ethyl Alcohol)IBA
08/2005 - 12/2002
3Interleukin 1 Receptor Antagonist Protein (Anakinra)FDA Link
05/2005 - 10/2002
2CollagenIBA
01/2011 - 10/2005
2Interleukin-6 (Interleukin 6)IBA
03/2009 - 11/2008
2ProstaglandinsIBA
03/2009 - 11/2008
2Proteins (Proteins, Gene)FDA Link
03/2009 - 11/2008
2LigandsIBA
03/2009 - 01/2009
2Transforming Growth Factor beta (TGF-beta)IBA
03/2009 - 11/2008
2PEGylated soluble tumor necrosis factor receptor IIBA
05/2005 - 10/2002
2Interleukin-1 (Interleukin 1)IBA
01/2004 - 10/2002
1InterleukinsIBA
03/2009
1AcidsIBA
03/2009
1Interleukin-18 (Interleukin 18)IBA
03/2009
1Glycoproteins (Glycoprotein)IBA
03/2009
1Interleukin-17 (Interleukin 17)IBA
03/2009
1Chemokine CCL2 (Monocyte Chemoattractant Protein 1)IBA
03/2009
1Orosomucoid (Seromucoid)IBA
01/2009
1CytokinesIBA
01/2009
1Receptor Activator of Nuclear Factor-kappa B (TRANCE-R)IBA
01/2009
1Dinoprostone (PGE2)FDA Link
01/2009
1Acute-Phase Proteins (Acute-Phase Protein)IBA
01/2009
1Tartrate-Resistant Acid PhosphataseIBA
01/2009
1Prostaglandins EIBA
11/2008
1Cathepsin KIBA
10/2005
1CarrageenanIBA
10/2005
1RANK LigandIBA
10/2005
1Parathyroid Hormone (Parathormone)IBA
05/2005
1Tumor Necrosis Factor InhibitorsIBA
05/2005
1Type I Tumor Necrosis Factor ReceptorsIBA
05/2005
1Interleukin-1 Receptors (Interleukin 1 Receptor)IBA
05/2005
1Fibroblast Growth Factor 2 (Basic Fibroblast Growth Factor)IBA
10/2002
1Nylons (Nylon)IBA
10/2002
1Intercellular Signaling Peptides and Proteins (Growth Factors)IBA
10/2002
1Vascular Endothelial Growth Factor A (Vascular Endothelial Growth Factor)IBA
10/2002
1Coloring Agents (Dyes)IBA
07/2002
1Tolonium ChlorideFDA Link
07/2002

Therapy/Procedure

3Therapeutics
01/2009 - 07/2002
1External Fixators
08/2005